Centene Corporation
Centene Corporation to Reaffirm 2024 Earnings Guidance at Barclays Healthcare Conference
Summary
On March 11, 2024, Centene Corporation announced that it will be presenting at the Barclays 26th Annual Global Healthcare Conference on March 12, 2024, at 8:00 a.m. EDT. During the presentation, the Company expects to reaffirm its previously issued 2024 adjusted diluted earnings per share (EPS) annual guidance of greater than $6.70. A live audio webcast of the presentation will be available at https://event.webcasts.com/starthere.jsp?ei=1659141&tp_key=18b8362d5e&tp_special=8, and a webcast replay will be accessible afterwards via the Company's website at www.centene.com, under the Investors section.
Profitelligence Alerts
Get alerts for CNC
Be first to know when Centene Corporation files with the SEC.
Filing Categories
Advertisement
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Official SEC Documents
Advertisement